Barclays’s Insys Therapeutics, Inc. INSY Stock Holding History

Barclays’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-900	Closed	-$3K	–	7554
2018 Q4	$3K	Sell	900 -700	-44%	-$4.87K	﹤0.01%	6674
2018 Q3	$16K	Buy	+1,600	New	+$12.8K	﹤0.01%	6536
2018 Q1	–	Sell	-1,000	Closed	-$10K	–	7527
2017 Q4	$10K	Buy	+1,000	New	+$6.54K	﹤0.01%	6523
2017 Q3	–	Sell	-1,800	Closed	-$23K	–	7191
2017 Q2	$23K	Buy	+1,800	New	+$21.3K	﹤0.01%	5750
2015 Q4	–	Sell	-593,800	Closed	-$16.6M	–	6902
2015 Q3	$16.6M	Hold	593,800	–	–	0.02%	683
2015 Q2	$20.8M	Buy	+593,800	New	+$18.5M	0.02%	633

Barclays's INSY Position: Q3 2019 in Review

Barclays sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 33,172 shares — an estimated $10K sold.

Barclays first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $5.19M in Q3 2015. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

Barclays reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Barclays sold 33,172 Insys Therapeutics, Inc. shares in Q3 2019, an estimated $10K.
Barclays first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
Barclays's Insys Therapeutics, Inc. position peaked at $5.19M in Q3 2015.
4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.